Login for students

Login for employees

Publication detail

Omega-3 fatty acid supplementation candidates can be selected using fatty acid profiling
Authors: Galuszka Jan | Vostalova Jitka | Cervena Blanka | Galuszkova Dana | Simanek Vilim | Holčapek Michal | Cífková Eva | Lísa Miroslav | Vrbkova Jana | Bancirova Martina | Taborsky Milos | Novotny Dalibor
Year: 2015
Type of publication: článek v odborném periodiku
Name of source: European Journal of Lipid Science and Technology
Publisher name: Wiley-VCH
Place: Weinheim
Page from-to: 601-607
Titles:
Language Name Abstract Keywords
cze Přidavky do potravin omega -3 mohou být vybrány na základě mastných kyselin Cílem práce bylo zhodnocení profilu mastných kyselin v plazmě a erytrocytech u zdravých mužů s rýznými kardiovaskulárními onemocněními. Mastné kyseliny v plazmě byly analyzovány v pěti skupinách pacientů ve věku 37-57 let. Profil mastných kyselin byl měřen pomocí plynové chromatografie s plamenově ionizační detekcí.
eng Omega-3 fatty acid supplementation candidates can be selected using fatty acid profiling The aim of this study was to evaluate the fatty acid(FA) profile in the plasma and erythrocyte membranes of apparently healthy men compared to male patients with various cardiovascular diseases (CVD). The plasma FA profiles were analyzed in five groups of subjects aged 37-57 years: groups 1 and 2 were male voluntary blood donors with a body mass index(BMI) 25.1 +/- 1.6,(Group1, N = 12) and a BMI 32.9 +/- 4.5, (Group 2, N = 11) respectively, male patients with chronic heart failure due to dilated cardiomyopathy (Group 3, N = 10), chronic atrial fibrillation without heart failure or coronary heart disease (Group 4, N = 10) and patients after myocardial infarction (Group 5, N = 11). The FA profile in plasma and erythrocytes was measured by gas chromatography (GC) with flame ionization detection and basic plasma lipid parameters were then estimated. Deficiencies of eicosapentaenoic acid and docosahexaenoic acid were found in all the groups of CVD patients and in Group 2 (BMI 32.9 +/- 4.5) of this Central European population. Unfavorable alterations in FA composition and clinical biochemistry parameters were found in patients with dilated cardiomyopathy (Group 3). Further, 75% of Group 1 (blood donors) had an average plasma PUFA level in the worst quartile for relative risk of cardiovascular events. Tailored n-3 PUFA supplementation should be recommended not only for secondary prevention in patients suffering from CVD but also for primary prevention in overweight and obese persons with a proven deficiency. Cardiovascular diseases; Lipidomics; n-3 PUFA; n-6 PUFA; Obesity

Departments

Other Parts

Map

en.mapy.cz

Services

Popular Links

© 2023 University of Pardubice, Studentská 95, 532 10 Pardubice 2
Phone: +420 466 036 111, 466 036 112, 466 036 113
Webmaster, RSS
Data box ID: f5vj9hu
Accessibility Statement
CC BY-NC-ND 4.0Creative CommonsAttributionNonCommercialNoDerivatives